top of page

The Science Behind EnLiSense

In the News

Advancing Care with Innovative Sweat Sensor Technology with Leading Clinicians

Peer Reviewed Science

Filter by Topics
yuvalna_minimal_studio_prodeuct_photogra

COVID severity test (CoST sensor)—An electrochemical immunosensing approach to stratify disease severity

Read More

Published by:

Bioengineering & Translational Medicine

Important Disclaimer

Guidance for Use

EnLiSense devices (IBD AWARE®, SWEAT AWARE®, and CORTITM) are for general wellness in healthy individuals, supporting health awareness, fitness, and lifestyle insights. They are not FDA-cleared and are not approved for diagnosing, treating, curing, preventing, or mitigating disease.
 

Non General Wellness Use Requires Clinical Oversight
Medical applications, including monitoring or managing diseases are still under investigation. Investigational use require supervision by qualified healthcare professionals in clinical or research settings.
 

No Medical Claims
Mentions of biomarkers or health conditions reflect research goals and are not evaluated by the FDA. All information is for education and wellness only, not as medical advice.
 

Consult Healthcare Professionals
Consult healthcare providers regarding medical concerns or symptoms. Device data does not replace professional medical advice, diagnosis, or treatment. Seek immediate care for urgent symptoms.
 

Limitations
Users accept all risks with device use. EnLiSense is not responsible for health outcomes from device use or data interpretation. Product features and capabilities may change as development continues.

© 2023 - 2025 by EnLiSense | Terms of Service & Privacy Policy

  • LinkedIn
bottom of page